GDF2產(chǎn)品信息
英文名稱:Growth/differentiation factor 2
中文名稱:骨形態(tài)發(fā)生蛋白-9
靶點(diǎn)別稱:GDF2,BMP9
物種:Human
屬性:Protein
標(biāo)記:Unconjugated
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in ACN, TFA in Water with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
GDF2分子背景
生長(zhǎng)分化因子2(GDF-2),也稱為骨形態(tài)發(fā)生蛋白9(BMP-9),是TGF-β超家族蛋白BMP亞組的成員,通過(guò)由I型和II型BMP受體組成的異二聚體復(fù)合物發(fā)出信號(hào)。GDF-2是血管生成的強(qiáng)效循環(huán)抑制劑。通過(guò)I型激活素受體ACVRL1發(fā)出信號(hào),但不通過(guò)其他Alks。內(nèi)皮細(xì)胞中通過(guò)SMAD1的信號(hào)傳導(dǎo)需要TGF-β輔助受體endoglin/ENG。ALK1是內(nèi)皮細(xì)胞(EC)中骨形態(tài)發(fā)生蛋白-9(BMP-9)的信號(hào)受體。BMP-9在轉(zhuǎn)染的COS細(xì)胞中與ALK1和endoglin高親和力結(jié)合,與I型受體ALK2和BMP II型受體(BMPR-II)和激活素II型受體的結(jié)合較弱。當(dāng)BMPR-II或ActR II共表達(dá)時(shí),BMP-9與ALK2的結(jié)合大大促進(jìn)。
關(guān)鍵字: GDF2;GDF2蛋白;BMP9蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。